4//SEC Filing
Bluestone Jeffrey 4
Accession 0001127602-25-019182
CIK 0000882095other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 3:59 PM ET
Size
8.5 KB
Accession
0001127602-25-019182
Insider Transaction Report
Form 4
Bluestone Jeffrey
Director
Transactions
- Sale
Common Stock
2025-07-14$109.74/sh−5,000$548,700→ 8,920 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-07-14−5,000→ 9,665 totalExercise: $67.45Exp: 2031-05-12→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-07-14$67.45/sh+5,000$337,250→ 13,920 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.
- [F2]25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001771814
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 3:59 PM ET
- Size
- 8.5 KB